^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

DS-3078

i
Other names: DS-3078, DS-3078a
Associations
Trials
Company:
Daiichi Sankyo
Drug class:
mTOR inhibitor
Related drugs:
Associations
Trials
almost4years
Small molecule CDS-3078 induces G/M phase arrest and mitochondria-mediated apoptosis in HeLa cells. (PubMed, Exp Ther Med)
Therefore, CDS-3078 administration induced apoptosis via p53-mediated cell cycle arrest, causing mitochondrial dysfunction and resulting in apoptotic cell death in cervical cancer cells. Collectively, the present results suggested that CDS-3078 may be a potential anticancer agent.
Journal
|
BCL2 (B-cell CLL/lymphoma 2)
|
TP53 expression
|
DS-3078